Copyright © 2008 David M. Aronoff and Zuber D. Mulla. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. D. Maharaj, “Puerperal pyrexia: a review. Part I,” Obstetrical & Gynecological Survey, vol. 62, no. 6, pp. 393–399, 2007. View at Publisher · View at Google Scholar · View at PubMed
2. G. Weissmann, “Puerperal priority,” The Lancet, vol. 349, no. 9045, pp. 122–125, 1997. View at Publisher · View at Google Scholar
3. J. R. Carapetis, A. C. Steer, E. K. Mulholland, and M. Weber, “The global burden of group A streptococcal diseases,” Lancet Infectious Diseases, vol. 5, no. 11, pp. 685–694, 2005. View at Publisher · View at Google Scholar · View at PubMed
4. I. Chuang, C. Van Beneden, B. Beall, and A. Schuchat, “Population-based surveillance for postpartum invasive group A streptococcus infections, 1995–2000,” Clinical Infectious Diseases, vol. 35, no. 6, pp. 665–670, 2002. View at Publisher · View at Google Scholar · View at PubMed
5. K. L. O'Brien, B. Beall, N. L. Barrett, et al., “Epidemiology of invasive group A Streptococcus disease in the United States, 1995–1999,” Clinical Infectious Diseases, vol. 35, no. 3, pp. 268–276, 2002. View at Publisher · View at Google Scholar · View at PubMed
6. Z. D. Mulla, P. E. Leaverton, and S. T. Wiersma, “Invasive group A streptococcal infections in Florida,” Southern Medical Journal, vol. 96, no. 10, pp. 968–973, 2003. View at Publisher · View at Google Scholar
7. Z. B. Nuwayhid, D. M. Aronoff, and Z. D. Mulla, “Blunt trauma as a risk factor for group A streptococcal necrotizing fasciitis,” Annals of Epidemiology, vol. 17, no. 11, pp. 878–881, 2007. View at Publisher · View at Google Scholar · View at PubMed
8. B. Schwartz, “Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition,” The Journal of the American Medical Association, vol. 269, no. 3, pp. 390–391, 1993. View at Publisher · View at Google Scholar
9. Z. D. Mulla, Invasive group A streptococcal infections in Florida: descriptive epidemiology and risk factors for hospital mortality, Ph.D. dissertation, University of South Florida, Tampa, Fla, USA, 2001.
10. E. Y. Anteby, S. Yagel, J. Hanoch, M. Shapiro, and A. E. Moses, “Puerperal and intrapartum group A streptococcal infection,” Infectious Diseases in Obstetrics and Gynecology, vol. 7, no. 6, pp. 276–282, 1999. View at Publisher · View at Google Scholar
11. M. Harper, E. Dugan, M. Espeland, A. Martinez-Borges, and C. McQuellon, “Why African-American women are at greater risk for pregnancy-related death,” Annals of Epidemiology, vol. 17, no. 3, pp. 180–185, 2007. View at Publisher · View at Google Scholar · View at PubMed
12. Z. D. Mulla, S. G. Gibbs, and D. M. Aronoff, “Correlates of length of stay, cost of care, and mortality among patients hospitalized for necrotizing fasciitis,” Epidemiology and Infection, vol. 135, no. 5, pp. 868–876, 2007. View at Publisher · View at Google Scholar · View at PubMed
13. Births, Florida Department of Health, Office of Planning, Evaluation & Data Analysis, October 2008, http://www.floridacharts.com/charts/chart.aspx.
14. D. L. Stevens, “Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment,” Emerging Infectious Diseases, vol. 1, no. 3, pp. 69–78, 1995.
15. R. U. Wahl, R. Lütticken, S. Stanzel, M. van der Linden, and R. R. Reinert, “Epidemiology of invasive Streptococcus pyogenes infections in Germany, 1996–2002: results from a voluntary laboratory surveillance system,” Clinical Microbiology and Infection, vol. 13, no. 12, pp. 1173–1178, 2007. View at Publisher · View at Google Scholar · View at PubMed
16. J. M. Sierra, F. Sánchez, P. Castro, et al., “Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003,” Medicine, vol. 85, no. 3, pp. 139–146, 2006. View at Publisher · View at Google Scholar · View at PubMed
17. M. H. Young, N. C. Engleberg, Z. D. Mulla, and D. M. Aronoff, “Therapies for necrotising fasciitis,” Expert Opinion on Biological Therapy, vol. 6, no. 2, pp. 155–165, 2006. View at Publisher · View at Google Scholar · View at PubMed
18. D. L. Stevens, “Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome?,” Clinical Infectious Diseases, vol. 21, no. 4, pp. 977–980, 1995.
19. Z. D. Mulla, “Nonsteroidal anti-inflammatory drugs and hypotension among patients hospitalized for invasive group A streptococcal disease,” Annals of Epidemiology, vol. 13, no. 7, pp. 543–544, 2003. View at Publisher · View at Google Scholar
20. D. M. Aronoff and K. C. Bloch, “Assessing the relationship between the use of nonsteroidal antiinflammatory drugs and necrotizing fasciitis caused by group A streptococcus,” Medicine, vol. 82, no. 4, pp. 225–235, 2003. View at Publisher · View at Google Scholar
21. D. M. Aronoff and Z. D. Mulla, “Nonsteroidal antiinflammatory drugs and group A streptococcal infection,” Emerging Infectious Diseases, vol. 12, no. 8, p. 1291, 2006.
22. D. E. Castagnola, M. K. Hoffman, J. Carlson, and C. Flynn, “Necrotizing cervical and uterine infection in the postpartum period caused by group A streptococcus,” Obstetrics & Gynecology, vol. 111, no. 2, part 2, pp. 533–535, 2008. View at Publisher · View at Google Scholar · View at PubMed
23. R. M. Silver, L. N. Heddleston, J. A. McGregor, and R. S. Gibbs, “Life-threatening puerperal infection due to a group A streptococci,” Obstetrics & Gynecology, vol. 79, no. 5, part 2, pp. 894–896, 1992.
24. Group A Streptococcal (GAS) Disease, Centers for Disease Control and Prevention, October 2008, http://www.cdc.gov/ncidod/dbmd/diseaseinfo/groupastreptococcal_g.htm#How%20is%20invas%20treated.
25. D. L. Stevens, A. L. Bisno, H. F. Chambers, et al., “Practice guidelines for the diagnosis and management of skin and soft-tissue infections,” Clinical Infectious Diseases, vol. 41, no. 10, pp. 1373–1406, 2005. View at Publisher · View at Google Scholar · View at PubMed
26. J. Zimbelman, A. Palmer, and J. Todd, “Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection,” Pediatric Infectious Disease Journal, vol. 18, no. 12, pp. 1096–1100, 1999. View at Publisher · View at Google Scholar
27. N. E. Russell and R. E. Pachorek, “Clindamycin in the treatment of streptococcal and staphylococcal toxic shock syndromes,” The Annals of Pharmacotherapy, vol. 34, no. 7, pp. 936–939, 2000. View at Publisher · View at Google Scholar
28. J.-S. Barry, J. A. Burge, D. B. Byles, and M. S. Morgan, “Severe invasive $\beta$ haemolytic group A streptococcal cellulitis and eyelid necrosis treated with linezolid,” British Journal of Ophthalmology, vol. 90, no. 9, p. 1204, 2006. View at Publisher · View at Google Scholar · View at PubMed
29. J. Raymond, L. Schlegel, F. Garnier, and A. Bouvet, “Molecular characterization of Streptococcus pyogenes isolates to investigate an outbreak of puerperal sepsis,” Infection Control & Hospital Epidemiology, vol. 26, no. 5, pp. 455–461, 2005. View at Publisher · View at Google Scholar · View at PubMed